Laurus Labs Limited (LAURUSLABS.BO)
INR 571.2
(0.69%)
INR 571.2
(0.69%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 24.62 Billion INR | -17.81% |
| 2022 | 31.73 Billion INR | 20.2% |
| 2021 | 26.4 Billion INR | 4.53% |
| 2020 | 25.25 Billion INR | 92.14% |
| 2019 | 13.14 Billion INR | 34.39% |
| 2018 | 9.78 Billion INR | 7.5% |
| 2017 | 9.09 Billion INR | 7.8% |
| 2016 | 8.44 Billion INR | 16.65% |
| 2015 | 7.23 Billion INR | 99.48% |
| 2014 | 3.62 Billion INR | 2.85% |
| 2013 | 3.52 Billion INR | 39.67% |
| 2012 | 2.52 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 3.78 Billion INR | -47.33% |
| 2024 Q2 | 6.75 Billion INR | 78.67% |
| 2023 Q3 | 6.49 Billion INR | 0.95% |
| 2023 FY | 26.08 Billion INR | -17.81% |
| 2023 Q2 | 6.43 Billion INR | 7.61% |
| 2023 Q1 | 5.97 Billion INR | 0.72% |
| 2023 Q4 | 7.17 Billion INR | 10.49% |
| 2022 Q3 | 8.25 Billion INR | -4.96% |
| 2022 Q1 | 8.85 Billion INR | 38.44% |
| 2022 Q4 | 5.93 Billion INR | -28.09% |
| 2022 FY | 31.73 Billion INR | 20.2% |
| 2022 Q2 | 8.68 Billion INR | -1.98% |
| 2021 Q4 | 6.39 Billion INR | 5.83% |
| 2021 Q2 | 6.7 Billion INR | -7.43% |
| 2021 Q3 | 6.04 Billion INR | -9.85% |
| 2021 FY | 26.4 Billion INR | 4.53% |
| 2021 Q1 | 7.24 Billion INR | 10.69% |
| 2020 Q2 | 6.37 Billion INR | 20.69% |
| 2020 Q3 | 7.05 Billion INR | 10.63% |
| 2020 Q4 | 6.54 Billion INR | -7.18% |
| 2020 FY | 25.25 Billion INR | 92.14% |
| 2020 Q1 | 5.28 Billion INR | 66.59% |
| 2019 Q4 | 3.17 Billion INR | -14.07% |
| 2019 Q1 | 2.76 Billion INR | 28.29% |
| 2019 Q2 | 3.52 Billion INR | 27.69% |
| 2019 Q3 | 3.69 Billion INR | 4.71% |
| 2019 FY | 13.14 Billion INR | 34.39% |
| 2018 Q1 | 2.43 Billion INR | -9.45% |
| 2018 FY | 9.78 Billion INR | 7.5% |
| 2018 Q4 | 2.15 Billion INR | -12.37% |
| 2018 Q3 | 2.45 Billion INR | -10.28% |
| 2018 Q2 | 2.73 Billion INR | 12.21% |
| 2017 Q3 | 2.33 Billion INR | -9.36% |
| 2017 Q4 | 2.69 Billion INR | 15.5% |
| 2017 FY | 9.09 Billion INR | 7.8% |
| 2017 Q1 | 2.32 Billion INR | -7.72% |
| 2017 Q2 | 2.57 Billion INR | 10.56% |
| 2016 Q1 | 1.97 Billion INR | 0.0% |
| 2016 Q4 | 2.52 Billion INR | 12.16% |
| 2016 FY | 8.44 Billion INR | 16.65% |
| 2016 Q3 | 2.24 Billion INR | -3.84% |
| 2016 Q2 | 2.33 Billion INR | 18.63% |
| 2015 FY | 7.23 Billion INR | 99.48% |
| 2014 FY | 3.62 Billion INR | 2.85% |
| 2013 FY | 3.52 Billion INR | 39.67% |
| 2012 FY | 2.52 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Ajanta Pharma Limited | 21.06 Billion INR | -16.882% |
| Amrutanjan Health Care Limited | 1.55 Billion INR | -1481.728% |
| Sigachi Industries Limited | 2 Billion INR | -1129.601% |
| Bal Pharma Limited | 770.19 Million INR | -3096.606% |
| Ind-Swift Laboratories Limited | 6.19 Billion INR | -297.46% |
| Medico Remedies Limited | 262.14 Million INR | -9291.823% |
| Lasa Supergenerics Limited | 121.02 Million INR | -20242.147% |
| Venus Remedies Limited | 2.18 Billion INR | -1028.025% |
| Sun Pharma Advanced Research Company Limited | -602.4 Million INR | 4186.961% |
| Alpa Laboratories Limited | 188.89 Million INR | -12933.749% |
| Nectar Lifesciences Limited | 2.97 Billion INR | -728.385% |
| Shilpa Medicare Limited | 3.54 Billion INR | -594.138% |
| Aarti Drugs Limited | 8.31 Billion INR | -196.05% |
| Lupin Limited | 123.71 Billion INR | 80.1% |
| Aurobindo Pharma Limited | 154.68 Billion INR | 84.084% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 80.337% |
| Windlas Biotech Limited | 1.33 Billion INR | -1738.968% |
| Suven Life Sciences Limited | -200.79 Million INR | 12361.189% |
| Eris Lifesciences Limited | 10.42 Billion INR | -136.123% |
| Valiant Laboratories Limited | -60.66 Million INR | 40684.366% |
| J. B. Chemicals & Pharmaceuticals Limited | 22.69 Billion INR | -8.459% |
| Solara Active Pharma Sciences Limited | 861.2 Million INR | -2758.813% |
| Ipca Laboratories Limited | 29.8 Billion INR | 17.41% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -566.23% |
| Achyut Healthcare Limited | 4.86 Million INR | -506382.205% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 90.475% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1572.782% |
| RPG Life Sciences Limited | 2.48 Billion INR | -891.547% |
| Mankind Pharma Limited | 44.52 Billion INR | 44.7% |
| Piramal Pharma Limited | 24.47 Billion INR | -0.61% |
| Syncom Formulations (India) Limited | 942.39 Million INR | -2512.492% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 47.345% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 8.068% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 64.494% |
| Unichem Laboratories Limited | 4.86 Billion INR | -406.073% |
| Sequent Scientific Limited | 2.97 Billion INR | -726.53% |
| Novartis India Limited | 1.32 Billion INR | -1755.46% |
| Wanbury Limited | 1.73 Billion INR | -1322.598% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -497.101% |
| Wockhardt Limited | 16.24 Billion INR | -51.602% |
| Themis Medicare Limited | 1.5 Billion INR | -1537.079% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -3672.675% |
| Jubilant Pharmova Limited | 19.64 Billion INR | -25.338% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -98.022% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 84.952% |
| Divi's Laboratories Limited | 32.44 Billion INR | 24.106% |
| NATCO Pharma Limited | 25.73 Billion INR | 4.336% |
| Gufic Biosciences Limited | 4.16 Billion INR | -490.735% |
| IOL Chemicals and Pharmaceuticals Limited | 4.58 Billion INR | -437.463% |
| Ind-Swift Limited | 2.17 Billion INR | -1033.245% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -325.85% |
| FDC Limited | 8.33 Billion INR | -195.391% |
| Krebs Biochemicals & Industries Limited | 192.72 Million INR | -12674.598% |
| Granules India Limited | 16.79 Billion INR | -46.554% |
| Medicamen Biotech Limited | 495.49 Million INR | -4868.789% |
| Alkem Laboratories Limited | 52.29 Billion INR | 52.922% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -295.65% |
| Biofil Chemicals and Pharmaceuticals Limited | 14.57 Million INR | -168765.615% |
| Brooks Laboratories Limited | 65.62 Million INR | -37419.201% |
| Megasoft Limited | 342.07 Million INR | -7097.365% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1843.354% |
| Strides Pharma Science Limited | 14.38 Billion INR | -71.114% |
| Neuland Laboratories Limited | 8.24 Billion INR | -198.504% |
| Morepen Laboratories Limited | 6.16 Billion INR | -299.594% |
| Hikal Limited | 3.14 Billion INR | -683.311% |
| Indoco Remedies Limited | 6.04 Billion INR | -307.528% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -322.202% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -3867.931% |
| Mangalam Drugs & Organics Limited | 703.6 Million INR | -3399.137% |
| Hester Biosciences Limited | 1.27 Billion INR | -1833.035% |